Besides, in TME, tumor cells and other immunosuppressive cells could express indoleamine 2,3-dioxygenase (IDO), which depletes tryptophan and results in the impairment of CD8+T cell cytotoxicity (Lamplugh and Fan, 2021). The gene discussed is IDO1; the disease is neoplasm.